InsidersTradesSigma
Total declarations
Company
▲ Purchases (23 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Ostronic Francis Patrick, Director. Director active across 1 companies, notably Cyclo Therapeutics, Inc.. In total, 29 reports have been recorded. Total volume traded: €210k. The latest transaction was filed on 20 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations29 total
€2312 shares@ €1.89050.0% of flow
Common Stock
SEC:0001437749-22-013286:0·
Ideal exit: 14 Feb 2023 (T+270)
05,249 shares0
Common Stock
SEC:0001437749-22-010958:0·
€13,3055,000 shares@ €2.6615.3% of flow
Common Stock
SEC:0001437749-22-008454:0·
€14,4285,000 shares@ €2.885712.1% of flow
Common Stock
SEC:0001437749-22-002467·
€14,4285,000 shares@ €2.88575.7% of flow
Common Stock
SEC:0001437749-22-002467:0·
05,065 shares0
Common Stock
SEC:0001437749-22-002055:0·
05,065 shares0
Common Stock
SEC:0001437749-22-002055·
€6,6132,000 shares@ €3.30645.5% of flow
Common Stock
SEC:0001437749-22-001472·
Ideal exit: 21 Oct 2022 (T+270)
€6,6132,000 shares@ €3.30642.6% of flow
Common Stock
SEC:0001437749-22-001472:0·
Ideal exit: 21 Oct 2022 (T+270)
€3,9971,132 shares@ €3.53063.3% of flow
Common Stock
SEC:0001437749-22-001184·
Ideal exit: 16 Oct 2022 (T+270)
€3,9971,132 shares@ €3.53061.6% of flow
Common Stock
SEC:0001437749-22-001184:0·
Ideal exit: 16 Oct 2022 (T+270)
€6,0431,731 shares@ €3.49135.1% of flow
Common Stock
SEC:0001437749-22-001015·
Ideal exit: 11 Oct 2022 (T+270)
€6,0431,731 shares@ €3.49132.4% of flow
Common Stock
SEC:0001437749-22-001015:0·
Ideal exit: 11 Oct 2022 (T+270)
€7,4612,137 shares@ €3.49136.2% of flow
Common Stock
SEC:0001437749-22-000925·
Ideal exit: 11 Oct 2022 (T+270)
€7,4612,137 shares@ €3.49133.0% of flow
Common Stock
SEC:0001437749-22-000925:0·
Ideal exit: 11 Oct 2022 (T+270)
€10,3903,000 shares@ €3.46328.7% of flow
Common Stock
SEC:0001437749-21-028623·
Ideal exit: 11 Sept 2022 (T+270)
€10,3903,000 shares@ €3.46324.1% of flow
Common Stock
SEC:0001437749-21-028623:0·
Ideal exit: 11 Sept 2022 (T+270)
€19,4815,000 shares@ €3.896116.3% of flow
Common Stock
SEC:0001437749-21-028294·
Ideal exit: 6 Sept 2022 (T+270)
€19,4815,000 shares@ €3.89617.7% of flow
Common Stock
SEC:0001437749-21-028294:0·
Ideal exit: 6 Sept 2022 (T+270)
€3,630864 shares@ €4.20123.0% of flow
Common Stock
SEC:0001437749-21-027904·
Ideal exit: 30 Aug 2022 (T+270)
€3,630864 shares@ €4.20121.4% of flow
Common Stock
SEC:0001437749-21-027904:0·
Ideal exit: 30 Aug 2022 (T+270)
€17,3564,136 shares@ €4.196314.5% of flow
Common Stock
SEC:0001437749-21-027685·
Ideal exit: 29 Aug 2022 (T+270)
€17,3564,136 shares@ €4.19636.9% of flow
Common Stock
SEC:0001437749-21-027685:0·
Ideal exit: 29 Aug 2022 (T+270)
€22,0655,000 shares@ €4.412918.5% of flow
Common Stock
SEC:0001437749-21-027642·
Ideal exit: 28 Aug 2022 (T+270)
€22,0655,000 shares@ €4.41298.7% of flow
Common Stock
SEC:0001437749-21-027642:0·
Ideal exit: 28 Aug 2022 (T+270)
25 of 29 declarations
About Ostronic Francis Patrick
Francis Patrick Ostronic is an executive at Cyclo Therapeutics, Inc.
